http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-4051276-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_eea20dc421b7ecf26781d0eb487fb83b
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-506
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-15
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-445
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D211-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-343
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4402
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-496
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-451
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-454
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-138
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C251-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D307-87
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-445
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-15
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-138
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-343
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-454
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D211-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D211-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C217-54
filingDate 2020-03-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_95057b550f719fc5751aee168a6f7328
publicationDate 2022-09-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-4051276-A1
titleOfInvention Use of glutamate 2b receptor antagonists and sigma receptor agonsists as antitussives
abstract The use of glutamate 2b receptor antagonists and sigma receptor agonists as antitussives to treat or prevent a cough is disclosed. In preferred embodiments, the glutamate 2b receptor antagonist is ifenprodil or radiprodil. Preferred sigma receptor agonists include fluvoxamine, fluoxetine, excitalpram, and donepezil.
priorityDate 2019-10-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419501289
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID5024
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419535600
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID228139
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60703
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID2904
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3667129
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512072
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419487901
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419499457
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24764487
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID444041
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419505100
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135423438
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3689
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID10280
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10200813
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419582371
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4054
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22880
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419557728
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419533756
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID100126610
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415879218
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID81739
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420712144
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID29336
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID100135589
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453221243
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419570570
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID40632
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419534500
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3152
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419592141
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID18391
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID494009
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419516952
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID219101
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID33032
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4737
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3386
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID446848
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5361192
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID24410
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID74441145
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID14812
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID58147
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID424707542
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID559976

Total number of triples: 84.